Rentokil Initial plcLSE: RTO

Rentokil Initial: Total Voting Rights

· Issued by Rentokil Initial plc via RNS

Summary by 6ix AI

Rentokil Initial plc said that as at October 30, 2026, its issued share capital consisted of 2,525,131,460 ordinary shares of 1 pence each, each carrying one vote, giving a total of 2,525,131,460 voting rights.

Key details

  • The company holds no shares in treasury (its own shares that it holds itself).
  • Shareholders may use the 2,525,131,460 figure as the denominator (the base number) in calculations to determine whether they are required to notify their interest in, or a change to their interest in, the company's share capital under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/total-voting-rights-1925

Watch Rentokil Initial's latest callRentokil Initial (LSE:RTO) Q3 2026 Earnings Call · Replay · Oct 22Read the transcript of Rentokil Initial (LSE:RTO) Q3 2026 Earnings Call
Rentokil Initial PLC
02 November 2026
 

2 November 2026

Rentokil Initial plc

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, Rentokil Initial plc (the “Company”) hereby notifies the market of the following:

As at 30 October 2026, the Company’s issued share capital consisted of 2,525,131,460 ordinary shares of 1 pence each with one voting right per share. The Company does not hold any shares in treasury.

Therefore, the total number of voting rights in the Company is 2,525,131,460.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

Enquiries:

Rachel Canham

Group General Counsel and Company Secretary

Tel: +44 (0)1293 858000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Rentokil Initial plc on 6ix

Story so far

Earlier from Rentokil Initial

All Rentokil Initial news releases